SCHEMBL22926317

SCHEMBL22926317

Cn1cc2cc(-c3ccc(C=O)cc3)ccc2n1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.41
CHRM1 P11229 8/20 0.40
DYRK3 O43781 3/20 0.39
CLK1 P49759 3/20 0.39
CLK2 P49760 3/20 0.39
DYRK1A Q13627 3/20 0.39
DYRK2 Q92630 3/20 0.39
CLK4 Q9HAZ1 3/20 0.39
DYRK1B Q9Y463 3/20 0.39
CLK3 P49761 2/20 0.39
DYRK4 Q9NR20 2/20 0.39
MAPT P10636 2/20 0.39
NSD2 O96028 1/20 0.39
ALDH1A1 P00352 1/20 0.39
BACE1 P56817 1/20 0.39
MAPKAPK2 P49137 1/20 0.39
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23497969 0.87 CYP2A6 (0.46) KDM4EDYRK3CLK1CLK2DYRK1A
SCHEMBL23498018 0.81 HDAC6 (0.36) KDM4EMAPTALDH1A1MAPKAPK2
SCHEMBL22130148 0.79 KDM4E (0.59) KDM4ECHRM1MAPTNSD2ALDH1A1
SCHEMBL28028402 0.79 BRAF (0.47) KDM4ECHRM1CLK1CLK2DYRK1A
SCHEMBL27914445 0.78 BACE1 (0.41) KDM4ECHRM1MAPTNSD2ALDH1A1
SCHEMBL6618268 0.78 KDM4E (0.43) KDM4ECHRM1MAPTNSD2ALDH1A1
Cyanide SCHEMBL22130052 0.77 KDM4E (0.39) KDM4ECHRM1DYRK3CLK1CLK2
SCHEMBL21604627 0.77 ALDH1A1 (0.56) KDM4EDYRK3CLK1CLK2DYRK1A
SCHEMBL29303290 0.76 KDM4E (0.42) KDM4ECHRM1MAPTNSD2ALDH1A1
SCHEMBL28499151 0.76 KIF11 (0.39) KDM4EDYRK1AMAPTALDH1A1MAPKAPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3587406-B1 2-HYDROXY-1-{4-[(4-PHENYLPHENYL)CARBONYL]PIPERAZIN-1-YL}ETHAN-1-ONE DERIVATIVES AND RELATED COMPOUNDS AS FATTY ACID SYNTHASE (FASN) INHIBITORS FOR THE TREATMENT OF CANCER FORMA THERAPEUTICS INC (US) 2021-01-27 EP disclosed